drugset / Trial / NCT00830388

Ketoconazole Foam 2% for the Treatment of Versicolor

NCT00830388

Phase 4 Completed 11 enrolled Boni Elewski, MD
NaSingle-groupOpen-labelTreatment

Summary

Ten adult patients age 19 and older with a clinical diagnosis of tinea versicolor, as well as a positive Potassium Hydroxide (KOH) using calcofluor. Ketoconazole 2% foam will be used to determine its effectiveness, safety and satisfaction when used to treat tinea versicolor.

Timeline

Start
2008-11
Primary completion
2010-08
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 2 % Topical

Indications